Patent details

EP2380587 Title: Use of C1 inhibitor for the prevention of ischemia-reperfusion injury

Basic Information

Publication number:
EP2380587
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP111728804
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
French Title of Invention:
Utilisation de l'inhibiteur C1 pour la prévention de blessure de reperfusion d'ischémie
German Title of Invention:
Verwendung eines C1-Hemmers zur Verhinderung eines ischämiebedingten Reperfusionsschadens
SPC Number:

Dates

Filing date:
19/12/2006
Grant date:
25/10/2017
EP Publication Date:
26/10/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/10/2017
EP B1 Publication Date:
25/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/12/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2017
 
 

Name:
Pharming Intellectual Property B.V.
Address:
Darwinweg 24, 2333 CR Leiden, Netherlands (NL)

Agent

Name:
Office FREYLINGER S.A.
From:
02/11/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Ziere, Gijsbertus Johannes
Address:
Netherlands (NL)

2

Name:
Pieper, Frank
Address:
Netherlands (NL)

3

Name:
Nuijens, Johannes Henricus
Address:
Netherlands (NL)

4

Name:
De Simoni, Maria Grazia
Address:
Italy (IT)

5

Name:
Mannesse, Maurice
Address:
Netherlands (NL)

Priority

1

Priority Number:
05112630
Priority Date:
21/12/2005
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
760944 P
Priority Date:
23/01/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/57; A61K 45/06; A61P 9/10; A61P 41/00;

Publication

European Patent Bulletin

Issue number:
201743
Publication date:
25/10/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
20
Annual Fee Amount:
300 Euro
Expected Payer:
Last Annual Fee Payment Date:
24/12/2024
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
IPAN GMBH
Filing date Document type Number of pages
02/11/2017 Power Of Attorney 1
13/11/2017 Outgoing Correspondence 1